发明名称 |
ANTI-IL1RAP ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND IL1RAP AND CD3, AND USES THEREOF |
摘要 |
Provided herein are antibodies that specifically bind to IL1RAP. Also described are related polynucleotides capable of encoding the provided IL1RAP-specific antibodies or antigen-binding fragments, cells expressing the provided antibodies or antigen-binding fragments, as well as associated vectors and detectably labeled antibodies or antigen-binding fragments. In addition, methods of using the provided antibodies are described. For example, the provided antibodies may be used to diagnose, treat, or monitor IL1RAP-expressing cancer progression, regression, or stability; to determine whether or not a patient should be treated for cancer; or to determine whether or not a subject is afflicted with IL1RAP-expressing cancer and thus may be amenable to treatment with an IL1RAP-specific anti-cancer therapeutic, such as the multispecific antibodies against IL1RAP and CD3 described herein. |
申请公布号 |
US2017121420(A1) |
申请公布日期 |
2017.05.04 |
申请号 |
US201615340149 |
申请日期 |
2016.11.01 |
申请人 |
Janssen Pharmaceutica NV |
发明人 |
Heidrich Bradley J.;Nemeth Jennifer F.;Nishioka, Jr. Walter K.;Dinh Thai;Cardoso Rosa Maria Fernandes;Pizutti Darlene;Strake Brandy;Fisher Jamie;Attar Ricardo Marcos;Gaudet Francois;Salvati Mark E. |
分类号 |
C07K16/30;A61K39/395;A61K45/06;C07K16/28;C07K16/46 |
主分类号 |
C07K16/30 |
代理机构 |
|
代理人 |
|
主权项 |
1. An isolated antibody, or an antigen-binding fragment thereof, that binds specifically to IL1RAP comprising:
an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 68 and a light chain sequence set forth in SEQ ID NO: 69; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 70 and a light chain sequence set forth in SEQ ID NO: 71; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 72 and a light chain sequence set forth in SEQ ID NO: 73; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 74 and a light chain sequence set forth in SEQ ID NO: 75; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 76 and a light chain sequence set forth in SEQ ID NO: 77; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 78 and a light chain sequence set forth in SEQ ID NO: 79; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 80 and a light chain sequence set forth in SEQ ID NO: 79; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 81 and a light chain sequence set forth in SEQ ID NO: 82; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 83 and a light chain sequence set forth in SEQ ID NO: 84; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 85 and a light chain sequence set forth in SEQ ID NO: 84; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 86 and a light chain sequence set forth in SEQ ID NO: 84; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 74 and a light chain sequence set forth in SEQ ID NO: 87; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 76 and a light chain sequence set forth in SEQ ID NO: 88; an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 76 and a light chain sequence set forth in SEQ ID NO: 89; or an antibody comprising a heavy chain sequence set forth in SEQ ID NO: 90 and a light chain sequence set forth in SEQ ID NO: 91. |
地址 |
Beerse BE |